Baidu
map
ARCH PHARM 润色咨询

ARCHIV DER PHARMAZIE

出版年份：1972 年文章数：935 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：9.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1196218, encodeId=ce0d1196218ef, content=这个审稿时间多久大概, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87876516693, createdName=ms6000000497540295, createdTime=Tue Feb 22 20:26:23 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087436, encodeId=6283108e436ee, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087435, encodeId=5b30108e43530, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540497, encodeId=5f3854049e58, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528145, encodeId=5bba5281452a, content=审稿速度:3.0<br>经验分享：可以投中药单体药理方向的文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e21953845, createdName=凝儿, createdTime=Wed Oct 12 09:53:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519459, encodeId=c97f5194595f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：审稿2-3个月，3个审稿人，共12条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a501690977, createdName=御风9179, createdTime=Wed Feb 24 13:27:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826025, encodeId=e44c826025fe, content=我们组以前发的基本都是一个月左右，我的审稿周期长了点（其间催过一次稿，编辑回复是没找够审稿人），最终只有一个审稿人的comments，不过修改后还是很快接受了，编辑还是很给力的。一般要有化合物的设计、合成、活性数据等，现在要求的越来越多了，不单纯是活性要好，相关实验要全。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Tue Jun 04 17:22:00 CST 2013, time=2013-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819383, encodeId=387e81938343, content=一般需要化合物设计合成、生物活性表征两个部分，生物活性表征可相对简单，但活性要求较好。杂志要求越来越高了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue May 08 08:33:00 CST 2012, time=2012-05-08, status=1, ipAttribution=)]
    2022-02-22 ms6000000497540295

    这个审稿时间多久大概

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1196218, encodeId=ce0d1196218ef, content=这个审稿时间多久大概, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87876516693, createdName=ms6000000497540295, createdTime=Tue Feb 22 20:26:23 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087436, encodeId=6283108e436ee, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087435, encodeId=5b30108e43530, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540497, encodeId=5f3854049e58, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528145, encodeId=5bba5281452a, content=审稿速度:3.0<br>经验分享：可以投中药单体药理方向的文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e21953845, createdName=凝儿, createdTime=Wed Oct 12 09:53:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519459, encodeId=c97f5194595f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：审稿2-3个月，3个审稿人，共12条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a501690977, createdName=御风9179, createdTime=Wed Feb 24 13:27:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826025, encodeId=e44c826025fe, content=我们组以前发的基本都是一个月左右，我的审稿周期长了点（其间催过一次稿，编辑回复是没找够审稿人），最终只有一个审稿人的comments，不过修改后还是很快接受了，编辑还是很给力的。一般要有化合物的设计、合成、活性数据等，现在要求的越来越多了，不单纯是活性要好，相关实验要全。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Tue Jun 04 17:22:00 CST 2013, time=2013-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819383, encodeId=387e81938343, content=一般需要化合物设计合成、生物活性表征两个部分，生物活性表征可相对简单，但活性要求较好。杂志要求越来越高了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue May 08 08:33:00 CST 2012, time=2012-05-08, status=1, ipAttribution=)]
    2021-12-29 MS68862005

    作者可以写中文名么？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1196218, encodeId=ce0d1196218ef, content=这个审稿时间多久大概, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87876516693, createdName=ms6000000497540295, createdTime=Tue Feb 22 20:26:23 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087436, encodeId=6283108e436ee, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087435, encodeId=5b30108e43530, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540497, encodeId=5f3854049e58, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528145, encodeId=5bba5281452a, content=审稿速度:3.0<br>经验分享：可以投中药单体药理方向的文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e21953845, createdName=凝儿, createdTime=Wed Oct 12 09:53:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519459, encodeId=c97f5194595f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：审稿2-3个月，3个审稿人，共12条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a501690977, createdName=御风9179, createdTime=Wed Feb 24 13:27:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826025, encodeId=e44c826025fe, content=我们组以前发的基本都是一个月左右，我的审稿周期长了点（其间催过一次稿，编辑回复是没找够审稿人），最终只有一个审稿人的comments，不过修改后还是很快接受了，编辑还是很给力的。一般要有化合物的设计、合成、活性数据等，现在要求的越来越多了，不单纯是活性要好，相关实验要全。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Tue Jun 04 17:22:00 CST 2013, time=2013-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819383, encodeId=387e81938343, content=一般需要化合物设计合成、生物活性表征两个部分，生物活性表征可相对简单，但活性要求较好。杂志要求越来越高了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue May 08 08:33:00 CST 2012, time=2012-05-08, status=1, ipAttribution=)]
    2021-12-27 Mia

    通讯作者最多有多少个？同第一作者最多有多少个？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1196218, encodeId=ce0d1196218ef, content=这个审稿时间多久大概, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87876516693, createdName=ms6000000497540295, createdTime=Tue Feb 22 20:26:23 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087436, encodeId=6283108e436ee, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087435, encodeId=5b30108e43530, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540497, encodeId=5f3854049e58, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528145, encodeId=5bba5281452a, content=审稿速度:3.0<br>经验分享：可以投中药单体药理方向的文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e21953845, createdName=凝儿, createdTime=Wed Oct 12 09:53:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519459, encodeId=c97f5194595f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：审稿2-3个月，3个审稿人，共12条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a501690977, createdName=御风9179, createdTime=Wed Feb 24 13:27:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826025, encodeId=e44c826025fe, content=我们组以前发的基本都是一个月左右，我的审稿周期长了点（其间催过一次稿，编辑回复是没找够审稿人），最终只有一个审稿人的comments，不过修改后还是很快接受了，编辑还是很给力的。一般要有化合物的设计、合成、活性数据等，现在要求的越来越多了，不单纯是活性要好，相关实验要全。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Tue Jun 04 17:22:00 CST 2013, time=2013-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819383, encodeId=387e81938343, content=一般需要化合物设计合成、生物活性表征两个部分，生物活性表征可相对简单，但活性要求较好。杂志要求越来越高了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue May 08 08:33:00 CST 2012, time=2012-05-08, status=1, ipAttribution=)]
    2017-07-18 13717005588

    可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1196218, encodeId=ce0d1196218ef, content=这个审稿时间多久大概, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87876516693, createdName=ms6000000497540295, createdTime=Tue Feb 22 20:26:23 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087436, encodeId=6283108e436ee, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087435, encodeId=5b30108e43530, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540497, encodeId=5f3854049e58, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528145, encodeId=5bba5281452a, content=审稿速度:3.0<br>经验分享：可以投中药单体药理方向的文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e21953845, createdName=凝儿, createdTime=Wed Oct 12 09:53:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519459, encodeId=c97f5194595f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：审稿2-3个月，3个审稿人，共12条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a501690977, createdName=御风9179, createdTime=Wed Feb 24 13:27:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826025, encodeId=e44c826025fe, content=我们组以前发的基本都是一个月左右，我的审稿周期长了点（其间催过一次稿，编辑回复是没找够审稿人），最终只有一个审稿人的comments，不过修改后还是很快接受了，编辑还是很给力的。一般要有化合物的设计、合成、活性数据等，现在要求的越来越多了，不单纯是活性要好，相关实验要全。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Tue Jun 04 17:22:00 CST 2013, time=2013-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819383, encodeId=387e81938343, content=一般需要化合物设计合成、生物活性表征两个部分，生物活性表征可相对简单，但活性要求较好。杂志要求越来越高了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue May 08 08:33:00 CST 2012, time=2012-05-08, status=1, ipAttribution=)]
    2016-10-12 凝儿

    审稿速度:3.0
    经验分享：可以投中药单体药理方向的文章么

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1196218, encodeId=ce0d1196218ef, content=这个审稿时间多久大概, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87876516693, createdName=ms6000000497540295, createdTime=Tue Feb 22 20:26:23 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087436, encodeId=6283108e436ee, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087435, encodeId=5b30108e43530, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540497, encodeId=5f3854049e58, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528145, encodeId=5bba5281452a, content=审稿速度:3.0<br>经验分享：可以投中药单体药理方向的文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e21953845, createdName=凝儿, createdTime=Wed Oct 12 09:53:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519459, encodeId=c97f5194595f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：审稿2-3个月，3个审稿人，共12条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a501690977, createdName=御风9179, createdTime=Wed Feb 24 13:27:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826025, encodeId=e44c826025fe, content=我们组以前发的基本都是一个月左右，我的审稿周期长了点（其间催过一次稿，编辑回复是没找够审稿人），最终只有一个审稿人的comments，不过修改后还是很快接受了，编辑还是很给力的。一般要有化合物的设计、合成、活性数据等，现在要求的越来越多了，不单纯是活性要好，相关实验要全。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Tue Jun 04 17:22:00 CST 2013, time=2013-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819383, encodeId=387e81938343, content=一般需要化合物设计合成、生物活性表征两个部分，生物活性表征可相对简单，但活性要求较好。杂志要求越来越高了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue May 08 08:33:00 CST 2012, time=2012-05-08, status=1, ipAttribution=)]
    2016-02-24 御风9179

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：审稿2-3个月，3个审稿人，共12条意见。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1196218, encodeId=ce0d1196218ef, content=这个审稿时间多久大概, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87876516693, createdName=ms6000000497540295, createdTime=Tue Feb 22 20:26:23 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087436, encodeId=6283108e436ee, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087435, encodeId=5b30108e43530, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540497, encodeId=5f3854049e58, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528145, encodeId=5bba5281452a, content=审稿速度:3.0<br>经验分享：可以投中药单体药理方向的文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e21953845, createdName=凝儿, createdTime=Wed Oct 12 09:53:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519459, encodeId=c97f5194595f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：审稿2-3个月，3个审稿人，共12条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a501690977, createdName=御风9179, createdTime=Wed Feb 24 13:27:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826025, encodeId=e44c826025fe, content=我们组以前发的基本都是一个月左右，我的审稿周期长了点（其间催过一次稿，编辑回复是没找够审稿人），最终只有一个审稿人的comments，不过修改后还是很快接受了，编辑还是很给力的。一般要有化合物的设计、合成、活性数据等，现在要求的越来越多了，不单纯是活性要好，相关实验要全。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Tue Jun 04 17:22:00 CST 2013, time=2013-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819383, encodeId=387e81938343, content=一般需要化合物设计合成、生物活性表征两个部分，生物活性表征可相对简单，但活性要求较好。杂志要求越来越高了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue May 08 08:33:00 CST 2012, time=2012-05-08, status=1, ipAttribution=)]
    2013-06-04 ms1706975392724364

    我们组以前发的基本都是一个月左右，我的审稿周期长了点（其间催过一次稿，编辑回复是没找够审稿人），最终只有一个审稿人的comments，不过修改后还是很快接受了，编辑还是很给力的。一般要有化合物的设计、合成、活性数据等，现在要求的越来越多了，不单纯是活性要好，相关实验要全。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1196218, encodeId=ce0d1196218ef, content=这个审稿时间多久大概, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87876516693, createdName=ms6000000497540295, createdTime=Tue Feb 22 20:26:23 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087436, encodeId=6283108e436ee, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087435, encodeId=5b30108e43530, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540497, encodeId=5f3854049e58, content=可恨，去年我发表了一篇，还有2分多，今年就1分多了，明年难道还要降？谁愿意投它呢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13717005588, createdTime=Tue Jul 18 18:43:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528145, encodeId=5bba5281452a, content=审稿速度:3.0<br>经验分享：可以投中药单体药理方向的文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6e21953845, createdName=凝儿, createdTime=Wed Oct 12 09:53:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519459, encodeId=c97f5194595f, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：审稿2-3个月，3个审稿人，共12条意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a501690977, createdName=御风9179, createdTime=Wed Feb 24 13:27:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=826025, encodeId=e44c826025fe, content=我们组以前发的基本都是一个月左右，我的审稿周期长了点（其间催过一次稿，编辑回复是没找够审稿人），最终只有一个审稿人的comments，不过修改后还是很快接受了，编辑还是很给力的。一般要有化合物的设计、合成、活性数据等，现在要求的越来越多了，不单纯是活性要好，相关实验要全。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Tue Jun 04 17:22:00 CST 2013, time=2013-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819383, encodeId=387e81938343, content=一般需要化合物设计合成、生物活性表征两个部分，生物活性表征可相对简单，但活性要求较好。杂志要求越来越高了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue May 08 08:33:00 CST 2012, time=2012-05-08, status=1, ipAttribution=)]
    2012-05-08 ms2506877623970506

    一般需要化合物设计合成、生物活性表征两个部分，生物活性表征可相对简单，但活性要求较好。杂志要求越来越高了。

    0

共10条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map